The Pathway to a Universal Influenza Vaccine

Catharine I. Paules, Hilary D. Marston, Robert W. Eisinger, David Baltimore, Anthony S. Fauci

Research output: Contribution to journalArticle

76 Scopus citations

Abstract

Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them. Development of a universal influenza vaccine is a research priority for the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. To facilitate this goal, we convened a workshop in Rockville, Maryland to identify knowledge gaps in influenza research and develop strategies to fill them.

Original languageEnglish (US)
Pages (from-to)599-603
Number of pages5
JournalImmunity
Volume47
Issue number4
DOIs
StatePublished - Oct 17 2017

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'The Pathway to a Universal Influenza Vaccine'. Together they form a unique fingerprint.

  • Cite this

    Paules, C. I., Marston, H. D., Eisinger, R. W., Baltimore, D., & Fauci, A. S. (2017). The Pathway to a Universal Influenza Vaccine. Immunity, 47(4), 599-603. https://doi.org/10.1016/j.immuni.2017.09.007